Susquehanna International Group
JBIO

Susquehanna International Group’s Jade Biosciences JBIO Stock Holding History

Susquehanna International Group’s Portfolio JBIO Stock Details JBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$257K Buy
+18,308
New +$265K ﹤0.01% 11207
2025
Q4 		– Sell
-17,653
Closed -$207K – 12320
2025
Q3 		$152K Sell
17,653
-21,576
-55% -$176K ﹤0.01% 11265
2025
Q2 		$392K Buy
39,229
+38,122
+3,444% +$1.3M ﹤0.01% 9739
2025
Q1 		$97.3K Sell
1,107
-543
-33% -$47.7K ﹤0.01% 11558
2024
Q4 		$153K Buy
+1,650
New +$142K ﹤0.01% 11003
2024
Q3 		– Sell
-2,039
Closed -$132K – 11943
2024
Q2 		$118K Buy
+2,039
New +$1.35M ﹤0.01% 10896
2022
Q1 		– Sell
-451
Closed -$186K – 12949
2021
Q4 		$186K Buy
+451
New +$228K ﹤0.01% 11526

Other funds holding JBIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Susquehanna International Group's JBIO Position: Q1 2026 in Review

Susquehanna International Group opened a new position in Jade Biosciences (JBIO) in Q1 2026: 18,308 shares worth $257K. The stake represents ﹤0.01% of the portfolio and ranks #11207 among its holdings. This is a return to the name: Susquehanna International Group previously reported a position in JBIO as recently as Q3 2025.

Susquehanna International Group first reported a position in JBIO in Q4 2021 and has held it in 7 quarters since. The position peaked at $392K in Q2 2025. 120 funds tracked by Wall St. Rank hold JBIO as of Q1 2026.

  • Susquehanna International Group held 18,308 shares of Jade Biosciences worth $257K as of Q1 2026.
  • Jade Biosciences was a new Susquehanna International Group position in Q1 2026.
  • Jade Biosciences made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #11207 holding.
  • Susquehanna International Group first reported a position in Jade Biosciences in Q4 2021 and has held it in 7 quarters since.
  • Susquehanna International Group's Jade Biosciences position peaked at $392K in Q2 2025.
  • 120 funds tracked by Wall St. Rank held Jade Biosciences as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.